Martin L. Stockley - Concepedia

Author

Martin L. Stockley

The Francis Crick Institute ORCID

Also Known As

Martin L. Stockley, Martin Stockley

Publications

970

Citations

H-Index

Concepts

All Affiliations

The Francis Crick Institute Newcastle University Babraham Institute University of York University of Oxford

About

Martin L. Stockley is an author at The Francis Crick Institute specializing in biomolecular engineering, natural sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	98
2	Natural Sciences	3	3	74
3	Biochemistry	3	3	111
4	Biomolecular Engineering	3	3	65
5	Engineering	2	2	49

Martin L. Stockley

Publications

866

Citations

H-Index

Page 1

	Year	Citations
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance Diana Zatreanu, Helen M.R. Robinson, Omar Alkhatib, Nature Communications	2021	336
Discovery of Potent Chromen-4-one Inhibitors of the DNA-Dependent Protein Kinase (DNA-PK) Using a Small-Molecule Library Approach Ian R. Hardcastle, Xiaoling Cockcroft, Nicola J. Curtin, Journal of Medicinal Chemistry	2005	169
Selective Benzopyranone and Pyrimido[2,1-<i>a</i>]isoquinolin-4-one Inhibitors of DNA-Dependent Protein Kinase: Synthesis, Structure−Activity Studies, and Radiosensitization of a Human Tumor Cell Line in Vitro Roger J. Griffin, Gabriele Fontana, Bernard T. Golding, Journal of Medicinal Chemistry	2004	141
CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound Ian T. Forbes, David G. Cooper, Emma K. Dodds, Bioorganic & Medicinal Chemistry Letters Ccr2b Receptor AntagonistsBiochemistryFunctional SelectivityMedicineG Protein-coupled Receptor	2000	53
Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta Martin L. Stockley, Amanda Ferdinand, Giovanni Benedetti, Journal of Medicinal Chemistry	2022	41
Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models Gonzalo Rodríguez‐Berriguete, Marco Ranzani, Remko Prevo, Clinical Cancer Research	2023	32
Synthesis, crystal structure determination, and biological properties of the DNA-dependent protein kinase (DNA-PK) inhibitor 3-cyano-6-hydrazonomethyl-5-(4-pyridyl)pyrid-[1H]-2-one (OK-1035) Martin L. Stockley, W. Clegg, Gabriele Fontana, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNucleic Acid ChemistryBiochemistryNatural SciencesRational Drug Design	2001	29
A versatile, non-biomimetic route to the preussomerins: syntheses of (±)-preussomerins F, K and L Ernesto Quesada, Martin L. Stockley, Jacques P. Ragot, Organic & Biomolecular Chemistry Natural Product SynthesisBioorganic ChemistryEngineeringBiochemistryAntifungal Agent	2004	29
The first total syntheses of (±)-Preussomerins K and L using 2-arylacetal anion technology Ernesto Quesada, Martin L. Stockley, Richard J. K. Taylor Tetrahedron Letters Engineering2-Arylacetal Anion TechnologyOrganic ChemistryFirst Total SynthesesChemistry	2004	20
Discovery, Development, and SAR of Aminothiazoles as LIMK Inhibitors with Cellular Anti-Invasive Properties Mark Charles, Joanna Brookfield, Tennyson Ekwuru, Journal of Medicinal Chemistry Drug TargetHigh ThroughputPharmacotherapyTumor BiologyDrug Resistance	2015	16

Page 1